Release Date: 19/10/22 10:20 Summary: Final Directors Interest Notice Price Sensitive: No Download Document 307.06KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%